164 related articles for article (PubMed ID: 19205026)
21. Modeling Williams syndrome with induced pluripotent stem cells.
Chailangkarn T; Muotri AR
Neurogenesis (Austin); 2017; 4(1):e1283187. PubMed ID: 28229087
[TBL] [Abstract][Full Text] [Related]
22. Duplication of GTF2I results in separation anxiety in mice and humans.
Mervis CB; Dida J; Lam E; Crawford-Zelli NA; Young EJ; Henderson DR; Onay T; Morris CA; Woodruff-Borden J; Yeomans J; Osborne LR
Am J Hum Genet; 2012 Jun; 90(6):1064-70. PubMed ID: 22578324
[TBL] [Abstract][Full Text] [Related]
23. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
[TBL] [Abstract][Full Text] [Related]
24. Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.
Antonell A; Del Campo M; Magano LF; Kaufmann L; de la Iglesia JM; Gallastegui F; Flores R; Schweigmann U; Fauth C; Kotzot D; Pérez-Jurado LA
J Med Genet; 2010 May; 47(5):312-20. PubMed ID: 19897463
[TBL] [Abstract][Full Text] [Related]
25. Loss of GTF2I promotes neuronal apoptosis and synaptic reduction in human cellular models of neurodevelopment.
Adams JW; Vinokur A; de Souza JS; Austria C; Guerra BS; Herai RH; Wahlin KJ; Muotri AR
Cell Rep; 2024 Mar; 43(3):113867. PubMed ID: 38416640
[TBL] [Abstract][Full Text] [Related]
26. Neuronal Gtf2i deletion alters mitochondrial and autophagic properties.
Nir Sade A; Levy G; Schokoroy Trangle S; Elad Sfadia G; Bar E; Ophir O; Fischer I; Rokach M; Atzmon A; Parnas H; Rosenberg T; Marco A; Elroy Stein O; Barak B
Commun Biol; 2023 Dec; 6(1):1269. PubMed ID: 38097729
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation profiles in individuals with rare, atypical 7q11.23 CNVs correlate with GTF2I and GTF2IRD1 copy number.
Strong E; Mervis CB; Tam E; Morris CA; Klein-Tasman BP; Velleman SL; Osborne LR
NPJ Genom Med; 2023 Sep; 8(1):25. PubMed ID: 37709781
[TBL] [Abstract][Full Text] [Related]
28. Deletion of
Ophir O; Levy G; Bar E; Kimchi Feldhorn O; Rokach M; Elad Sfadia G; Barak B
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626769
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization (FISH) as an irreplaceable diagnostic tool for Williams-Beuren syndrome in developing countries: a literature review.
Carlotto BS; Deconte D; Diniz BL; Silva PRD; Zen PRG; Silva AAD
Rev Paul Pediatr; 2023; 42():e2022125. PubMed ID: 37436242
[TBL] [Abstract][Full Text] [Related]
30. A Large Turkish Cohort of Williams Syndrome: The Evaluation of Facial, Cardiovascular, and Neuropsychiatric Features.
Bozlak S; Uludağ Alkaya D; Kasap B; Yüksel Ülker A; Yıldız CA; Altındağ V; Ülkersoy İ; Çifçi Sunamak E; Dedeoğlu R; Tüysüz B
Turk Arch Pediatr; 2023 Mar; 58(2):182-188. PubMed ID: 36856356
[TBL] [Abstract][Full Text] [Related]
31. Biallelic GTF2IRD1 variants in brothers with profound neurodevelopmental disorder: A possible novel disorder involving a critical gene for Williams syndrome.
Cummings CT; Starr LJ
Am J Med Genet A; 2023 Feb; 191(2):332-337. PubMed ID: 36308390
[TBL] [Abstract][Full Text] [Related]
32. Identification of a transcriptional signature found in multiple models of ASD and related disorders.
Thudium S; Palozola K; L'Her É; Korb E
Genome Res; 2022 Sep; 32(9):1642-54. PubMed ID: 36104286
[TBL] [Abstract][Full Text] [Related]
33. Oxytocin and Oxytocin Receptor Gene Regulation in Williams Syndrome: A Systematic Review.
Çalışkan E; Şahin MN; Güldağ MA
Yale J Biol Med; 2021 Dec; 94(4):623-635. PubMed ID: 34970101
[TBL] [Abstract][Full Text] [Related]
34. Williams syndrome.
Kozel BA; Barak B; Kim CA; Mervis CB; Osborne LR; Porter M; Pober BR
Nat Rev Dis Primers; 2021 Jun; 7(1):42. PubMed ID: 34140529
[TBL] [Abstract][Full Text] [Related]
35. Core transcriptional networks in Williams syndrome: IGF1-PI3K-AKT-mTOR, MAPK and actin signaling at the synapse echo autism.
Dai L; Weiss RB; Dunn DM; Ramirez A; Paul S; Korenberg JR
Hum Mol Genet; 2021 Apr; 30(6):411-429. PubMed ID: 33564861
[TBL] [Abstract][Full Text] [Related]
36. Postnatal therapeutic approaches in genetic neurodevelopmental disorders.
Levy G; Barak B
Neural Regen Res; 2021 Mar; 16(3):414-422. PubMed ID: 32985459
[TBL] [Abstract][Full Text] [Related]
37. The sociability spectrum: evidence from reciprocal genetic copy number variations.
López-Tobón A; Trattaro S; Testa G
Mol Autism; 2020 Jun; 11(1):50. PubMed ID: 32546261
[TBL] [Abstract][Full Text] [Related]
38. Functions of Gtf2i and Gtf2ird1 in the developing brain: transcription, DNA binding and long-term behavioral consequences.
Kopp ND; Nygaard KR; Liu Y; McCullough KB; Maloney SE; Gabel HW; Dougherty JD
Hum Mol Genet; 2020 Jun; 29(9):1498-1519. PubMed ID: 32313931
[TBL] [Abstract][Full Text] [Related]
39. Social, neurodevelopmental, endocrine, and head size differences associated with atypical deletions in Williams-Beuren syndrome.
Lugo M; Wong ZC; Billington CJ; Parrish PCR; Muldoon G; Liu D; Pober BR; Kozel BA
Am J Med Genet A; 2020 May; 182(5):1008-1020. PubMed ID: 32077592
[TBL] [Abstract][Full Text] [Related]
40. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
Kopp N; McCullough K; Maloney SE; Dougherty JD
Hum Mol Genet; 2019 Oct; 28(20):3443-3465. PubMed ID: 31418010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
